CARLSMED, INC.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
CARL$14.52-5.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED BALANCE SHEETS
(in thousands, except for share and par value amounts)
(unaudited)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $73,016 | $85,793 |
| Restricted cash | 100 | 100 |
| Short-term investments | 24,000 | 24,000 |
| Accounts receivable, net of allowances of $2,055 and $1,653, as of March 31, 2026 and December 31, 2025, respectively | 12,268 | 11,362 |
| Inventory | 2,063 | 1,845 |
| Prepaid expenses and other current assets | 3,959 | 3,573 |
| Total current assets | 115,406 | 126,673 |
| Property and equipment, net | 1,597 | 1,487 |
| Operating lease right-of-use assets | 1,663 | 1,826 |
| Other assets | 103 | 134 |
| Total assets | $118,769 | $130,120 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,952 | $4,481 |
| Accrued liabilities | 3,202 | 3,287 |
| Accrued compensation | 2,785 | 5,760 |
| Short-term operating lease liabilities | 776 | 752 |
| Total current liabilities | 9,715 | 14,280 |
| Long-term portion of term loan, net | 15,364 | 15,346 |
| Long-term operating lease liabilities | 1,115 | 1,316 |
| Other long-term liabilities | 327 | 309 |
| Total liabilities | 26,521 | 31,251 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.00001 par value; 10,000,000 shares authorized and zero shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.00001 par value; 600,000,000 shares authorized, 27,232,278 shares issued, and 27,181,501 shares outstanding as of March 31, 2026; 600,000,000 shares authorized, 26,664,243 shares issued, and 26,604,505 shares outstanding as of December 31, 2025 | — | — |
| Additional paid-in capital | 201,749 | 199,674 |
| Accumulated deficit | (109,501) | (100,805) |
| Total stockholders’ equity | 92,248 | 98,869 |
| Total liabilities and stockholders’ equity | $118,769 | $130,120 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.